Featured Products

Our Promise to You

Guaranteed product quality, expert customer support

Our Promise to You

ONLINE INQUIRY

Immortalized Mouse Astrocytes-SV40T (IMA2.1)

Cat.No.: CSC-I9175L

Species: Mus musculus

Source: Cerebral Cortex

Morphology: star-shape morphology

Culture Properties: Adherent

  • Specification
  • Background
  • Scientific Data
  • Q & A
  • Customer Review
Cat.No.
CSC-I9175L
Description
The Immortalized Mouse Astrocytes- SV40 T (IMA 2.1) is a suitable cell line for studies in astrocyte functions. This cell line is unique in that it is capable of metabolizing the parkinsonian toxin MPTP (to MPP+) and is responsive to pro-inflammatory stimuli. In addition, this cell line can be used in neuronal co-culture studies to simulate conditions in the brain.Upon stimulation with cytokines such as IL-1β, TNF-α and IFN-γ, these cells show up-regulated NOS-2 and COX-2 mRNA expression and release various inflammatory mediators. This cell line has a stable star-shape morphology and expresses immature astrocyte markers such as nestin and CD44, indicating that the cells are of the early-stage astrocyte precursor phenotype. Furthermore, they are capable of converting glutamate via glutamine synthase to glutamine, which is a characteristic of GFAP-negative astrocytes.
Species
Mus musculus
Source
Cerebral Cortex
Culture Properties
Adherent
Morphology
star-shape morphology
Immortalization Method
Serial passaging and transfection with psV3neo plasmid carrying SV40 large T antigen genes
Markers
Nestin, CD44
Applications
For Research Use Only
Storage
Directly and immediately transfer cells from dry ice to liquid nitrogen upon receiving and keep the cells in liquid nitrogen until cell culture needed for experiments.

Note: Never can cells be kept at -20 °C.
Shipping
Dry Ice.
Recommended Products
CSC-C4464X Mouse Astrocytes Hippocampal
CSC-C4465X Mouse Astrocytes Cortex
CSC-C4466X Mouse Astrocytes Cerebellar
CIK-HT003 HT® Lenti-SV40T Immortalization Kit
Quality Control
The cell line's response to pro-inflammatory stimuli was measured by
1) immunostaining to assess NF-kB translocation from the cytosol to the nucleus;
2) RT-qPCR and quantitative PCR detection of NOS-2 mRNA levels;
3) Western Blot analysis of NOS-2 and COX2 proteins.
BioSafety Level
II
Citation Guidance
If you use this products in your scientific publication, it should be cited in the publication as: Creative Bioarray cat no. If your paper has been published, please click here to submit the PubMed ID of your paper to get a coupon.

The Immortalized Mouse Astrocytes-SV40T (IMA2.1) cell line comes from mouse astrocytes modified with the SV40 Large T Antigen. Researchers often use these cells to study what astrocytes do and how they contribute to brain diseases. IMA 2.1 cells carry markers of immature astrocyte, like nestin and CD44. They can convert MPTP into MPP+ and change glutamate into glutamine. These cells are also very responsive to cytokines that cause inflammation, such as IL-1β, TNF-α, and IFN-γ. When exposed to these cytokines, they increase the activity of certain genes, like NOS-2 and COX-2, and release substances that cause inflammation.

Their sensitivity to inflammation makes IMA 2.1 cells perfect for lab models that explore how inflammation works. Scientists expose these cells to substances like lipopolysaccharide and various inflammatory cytokines such as TNF-α, IL-1β, and IFN-γ, either alone or in combination, to see how astrocytes react. This includes observing cellular morphological changes, the secretion of inflammatory factors, and the activation of intracellular signaling pathways under inflammatory stimuli. Because astrocytes are critical components of the nervous system, IMA 2.1 cells are also used to study changes during brain diseases and injuries, helping us understand how these conditions develop at the cellular level.

IMA 2.1 and primary mouse astrocytes were examined for their traits. They were stained for CD44 and nestin (in green) and their nuclei were marked with H-33342 (in red). Phalloidin was used to highlight cell shape by targeting F-actin. Fig. 1. Phenotypic and functional characteristics of IMA 2.1 and primary mouse astrocytes. They were stained for CD44 and nestin (in green) and their nuclei were marked with H-33342 (in red). Phalloidin was used to highlight cell shape by targeting F-actin (Schildknecht S, Kirner S, et al., 2012).

GPNMB Signaling in Astrocyte Cultures

Neuroinflammation, a pivotal feature of neurodegenerative diseases like Parkinson's disease (PD), involves glial cell activation and inflammatory response. Glycoprotein non-metastatic melanoma protein B (GPNMB), a transmembrane glycoprotein, has shown neuroprotective properties in diseases like ALS, yet its mechanism in PD remains underexplored. Using immortalized mouse astrocytes (IMA2.1) and primary mouse astrocytes (PMAs), Neal's team assesed GPNMB's impact on cytokine-induced astrocyte activation.

Following MPTP treatment, increased CD44 levels in astrocytes were observed. Then, they used the IMA2.1 and PMAs to assess GPNMB and CD44 expression. Previously, Yu et al. found IL-4 significantly increased GPNMB expression in mesenchymal stem cells, unlike LPS and IFNγ. Neal et al. tested if astrocytes behaved similarly by treating them with either pro-inflammatory cytokines (TNFα, IL-1β, IFNγ) or IL-4. Both cell types expressed GPNMB, with IL-4 enhancing expression, while pro-inflammatory cytokines did not (Fig. 1a and b). GPNMB protein rise was confirmed in astrocytes post-IL-4. Both cell types also expressed CD44, which increased with pro-inflammatory cytokines (Fig. 1c and d). IL-4 boosted CD44 protein but not gene expression. Increased CD44 may stem from reduced degradation. These findings suggest GPNMB-CD44 signaling adjusts inflammatory responses, with CD44 rising after pro-inflammatory stimuli and GPNMB after anti-inflammatory stimuli.

Cultured astrocytes show higher levels of GPNMB and CD44 when exposed to various stimuli.Fig. 1. Increased GPNMB and CD44 in cultured astrocytes exposed to different stimuli (Neal M L, Boyle A M, et al., 2018).

Establishment of the LUHMES and IMA Cells Co-culture Model

PD's development involves dopaminergic neuron degeneration, necessitating new human-based models for neuroprotective drug testing. Current models lack neuron-glia interactions vital for metabolism and neurotoxicity studies. Efremova's team developed an in vitro model using human dopaminergic neurons (LUHMES) co-cultured with Immortalized mouse astrocyte cell line (IMA 2.1), recreating MPTP metabolism.

For co-culturing with LUHMES neurons, IMA 2.1 or mixed primary glial cells were seeded in multi-well plates in DMEM with supplements at a density of 15,000 cm−2. After 24 hours, LUHMES differentiation medium was added for 2 days. Pre-differentiated LUHMES cells were then placed on astrocytes at 300,000 cells per well and differentiated for another 4 days. On day 6, the astrocyte:neuron ratio was 1.3, used for MPTP and drug treatments (Fig. 2B). Immunostaining with specific antibodies identified cell types, showing LUHMES layered on astrocytes. The culture maintained a reproducible neuron differentiation with IMA 2.1 astrocytes, similar to mono-cultures (Fig. 2C). Co-cultured neurons had more tyrosine hydroxylase and dopamine (Fig. 2D; Fig.3A) and expressed TH, DAT, and the vesicular monoamine transporter (Fig. 2E; Fig.3B).

Illustration and description of neuron–astrocyte co-cultures.Fig. 2. Schematic representation and phenotypic characterization of neuron–astrocyte co-cultures (Efremova L, Schildknecht S, et al., 2015).

Dopaminergic traits of LUHMES when grown alone and when grown with astrocytes.Fig. 3. Dopaminergic characteristics of LUHMES differentiated in mono-culture and in co-culture with astrocytes (Efremova L, Schildknecht S, et al., 2015).

Ask a Question

Write your own review

For research use only. Not for any other purpose.